This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec;10(12):e109.

doi: 10.1016/S2213-2600(22)00402-7. Epub 2022 Oct 22.

Standardising corticosteroid use in acute respiratory distress syndrome

Steven M Lemieux¹

Affiliations

PMID: 36279881
DOI: 10.1016/S2213-2600(22)00402-7

Comment

Standardising corticosteroid use in acute respiratory distress syndrome

Steven M Lemieux. Lancet Respir Med. 2022 Dec.

. 2022 Dec;10(12):e109.

doi: 10.1016/S2213-2600(22)00402-7. Epub 2022 Oct 22.

Author

Steven M Lemieux¹

Affiliation

¹ VA Connecticut Healthcare System, West Haven, CT 06516, USA. Electronic address: steven.lemieux@va.gov.

PMID: 36279881
DOI: 10.1016/S2213-2600(22)00402-7

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests.

Comment on

Opportunities for improved clinical trial designs in acute respiratory distress syndrome.
Wick KD, Aggarwal NR, Curley MAQ, Fowler AA 3rd, Jaber S, Kostrubiec M, Lassau N, Laterre PF, Lebreton G, Levitt JE, Mebazaa A, Rubin E, Sinha P, Ware LB, Matthay MA. Wick KD, et al. Lancet Respir Med. 2022 Sep;10(9):916-924. doi: 10.1016/S2213-2600(22)00294-6. Lancet Respir Med. 2022. PMID: 36057279 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science